LENVIMA (lenvatinib) capsules
LENVIMA is a brand-name prescription medication that’s used to treat certain types of endometrial cancer, renal cell carcinoma (a type of kidney cancer), hepatocellular carcinoma (a type of liver cancer), and thyroid cancer.. LENVIMA (lenvatinib) capsules, for oral use Initial U.S. Approval: 2015
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Overseas Patient/ Export inquires.
Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
LENVIMA (lenvatinib) capsules
Lenvatinib mesylate is approved to be used alone or with other drugs to treat: Endometrial carcinoma, Hepatocellular carcinoma (a type of liver cancer), Renal cell carcinoma (a type of kidney cancer), Thyroid cancer. Lenvatinib mesylate is also being studied in the treatment of other types of cancer.
LENVIMA, A drug used alone or with other drugs to treat certain types of endometrial cancer, renal cell carcinoma (a type of kidney cancer), hepatocellular carcinoma (a type of liver cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. Lenvima blocks certain proteins, which may help keep cancer cells from growing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Lenvima is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called lenvatinib mesylate.
lenvatinib mesylate, A drug used alone or with other drugs to treat certain types of endometrial cancer, renal cell carcinoma (a type of kidney cancer), hepatocellular carcinoma (a type of liver cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. Lenvatinib mesylate blocks certain proteins, which may help keep cancer cells from growing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Lenvatinib mesylate is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called Lenvima. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lenvatinib-mesylate
Drug (Brand / Generic): LENVIMA / lenvatinib capsules
Current Indications: endometrial cancer, renal cell carcinoma, hepatocellular carcinoma and thyroid cancer
Marketed by:: Eisai Inc
Approval Date: 2015
Available as (Form & Strength): Capsules: 4 mg and 10 mg. LENVIMA 4 mg capsules are supplied as hard hypromellose capsules with yellowish-red body and yellowish-red cap, marked in black ink with “Є” on the cap and “LENV 4 mg” on the body. LENVIMA 10 mg capsules are supplied as hard hypromellose capsules with yellow body and yellowish-red cap, marked in black ink with “Є” on the cap and “LENV 10 mg” on the body
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier / importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “LENVIMA (lenvatinib) capsules”.
Confirmation of the order for LENVIMA (lenvatinib) capsules will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand LENVIMA (lenvatinib) capsules. The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to LENVIMA (lenvatinib) capsules, they can inquire and find further information by sending their inquiries to ALS.
We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.
Kindly reach out to us for LENVIMA (lenvatinib) capsules price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
